{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:58:52Z","timestamp":1789610332922,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023368","name":"Eisai Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.sleep.2025.108722","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:43:12Z","timestamp":1766122992000},"page":"108722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorder"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2561-9785","authenticated-orcid":false,"given":"Wei-Feng","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Moline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2025.108722_bib1","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04071","article-title":"Prevalence of sleep disturbances and associated factors among Chinese residents: a web-based empirical survey of 2019","volume":"13","author":"Wang","year":"2023","journal-title":"J Glob Health"},{"issue":"5","key":"10.1016\/j.sleep.2025.108722_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2025.108722_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4866","article-title":"Digital cognitive behavioral therapy for insomnia using a smartphone application in China: a pilot randomized clinical trial","volume":"6","author":"Zhang","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.sleep.2025.108722_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jsmc.2019.01.008","article-title":"Delivering cognitive behavioral therapy for insomnia in the real world: considerations and controversies","volume":"14","author":"Buenaver","year":"2019","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.sleep.2025.108722_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.915823","article-title":"Trends in prescriptions for insomnia in a province in China between 2015 and 2019","volume":"13","author":"Lou","year":"2022","journal-title":"Front Psychiatr"},{"issue":"15","key":"10.1016\/j.sleep.2025.108722_bib6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2174\/1381612827666210917145636","article-title":"BDZs, designer BDZs and Z-drugs: pharmacology and misuse insights","volume":"28","author":"Zaami","year":"2022","journal-title":"Curr Pharm Des"},{"issue":"9","key":"10.1016\/j.sleep.2025.108722_bib7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00228-022-03354-7","article-title":"Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use","volume":"78","author":"Mattioli","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.sleep.2025.108722_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ijnp\/pyab073","article-title":"Benzodiazepine and Z-drug use and the risk of developing dementia","volume":"25","author":"Torres-Bondia","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2025.108722_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","article-title":"The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases","volume":"11","author":"Wang","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"10.1016\/j.sleep.2025.108722_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.sleep.2025.108722_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa123","article-title":"Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2","volume":"43","author":"K\u00e4rpp\u00e4","year":"2020","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.sleep.2025.108722_bib12","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/jcph.1683","article-title":"Population pharmacokinetics and exposure-response analyses for the most frequent adverse events following treatment with lemborexant, an orexin receptor antagonist, in subjects with insomnia disorder","volume":"60","author":"Lalovic","year":"2020","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.sleep.2025.108722_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jcph.2192","article-title":"Exposure-response analyses of polysomnography and subjective sleep efficacy end points from the phase 3 trials of lemborexant, a dual orexin receptor antagonist for the treatment of insomnia","volume":"63","author":"Lalovic","year":"2023","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.sleep.2025.108722_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleepx.2023.100098","article-title":"Transitioning insomnia patients from zolpidem to lemborexant: a multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy","volume":"7","author":"Ahmad","year":"2024","journal-title":"Sleep Med X"},{"key":"10.1016\/j.sleep.2025.108722_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/NSS.S448871","article-title":"Assessing the real-world, long-term impact of lemborexant on sleep quality in a home-based clinical study","volume":"16","author":"Miyata","year":"2024","journal-title":"Nat Sci Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2025.108722_bib16","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1007\/s12325-024-02811-2","article-title":"Efficacy and safety of transitioning to lemborexant from Z-drug, suvorexant, and ramelteon in Japanese insomnia patients: an open-label, multicenter study","volume":"41","author":"Ozone","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.sleep.2025.108722_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleepx.2025.100149","article-title":"Self-reported sleep variables, sleep quality, and quality of life assessment in transition to lemborexant in patients with insomnia: the multicenter, open-label SOMNUS study","volume":"10","author":"Ozone","year":"2025","journal-title":"Sleep Med X"},{"issue":"3","key":"10.1016\/j.sleep.2025.108722_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.70054","article-title":"Effect of lemborexant-based sleep medication formulary on benzodiazepine reduction and clinical outcomes: a single-center retrospective study","volume":"45","author":"Aoki","year":"2025","journal-title":"Neuropsychopharmacol Rep"},{"issue":"1","key":"10.1016\/j.sleep.2025.108722_bib19","article-title":"Comparative efficacy and safety of suvorexant and lemborexant for insomnia treatment","volume":"2","author":"Hayashi","year":"2023","journal-title":"PCN Rep"},{"key":"10.1016\/j.sleep.2025.108722_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/IJGM.S452278","article-title":"The administration of lemborexant at admission is not associated with inpatient falls: a multicenter retrospective observational study","volume":"17","author":"Hirata","year":"2024","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.sleep.2025.108722_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleepx.2023.100070","article-title":"Safety and real-world efficacy of lemborexant in the treatment of comorbid insomnia","volume":"5","author":"Katsuta","year":"2023","journal-title":"Sleep Med X"},{"issue":"10","key":"10.1016\/j.sleep.2025.108722_bib22","article-title":"Short-term efficacy and safety of suvorexant and lemborexant: a retrospective study","volume":"16","author":"Mori","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.sleep.2025.108722_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2868","article-title":"Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma-aminobutyric acid-benzodiazepine receptor agonists or suvorexant","volume":"38","author":"Okino","year":"2023","journal-title":"Hum Psychopharmacol"},{"issue":"4","key":"10.1016\/j.sleep.2025.108722_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5664\/jcsm.10946","article-title":"A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists","volume":"20","author":"Tachibana","year":"2024","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"10.1016\/j.sleep.2025.108722_bib25","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1080\/14656566.2024.2392018","article-title":"Evaluation of prescribing patterns of switching to and add-on lemborexant in patients treated with hypnotic medication: a nationwide claims database study in Japan","volume":"25","author":"Tanaka-Mizuno","year":"2024","journal-title":"Expet Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.sleep.2025.108722_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40268-024-00462-w","article-title":"Safety and efficacy of lemborexant in insomnia patients: results of a postmarketing observational study of Dayvigo tablets","volume":"24","author":"Mishima","year":"2024","journal-title":"Drugs R&D"},{"issue":"7","key":"10.1016\/j.sleep.2025.108722_bib27","article-title":"Lemborexant for the treatment of insomnia in patients from China: four case studies","volume":"16","author":"Jian","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.sleep.2025.108722_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1495965","article-title":"Efficacy and safety of lemborexant in treating adult patients with insomnia in China: a single-center, retrospective observational study","volume":"16","author":"Jian","year":"2025","journal-title":"Front Neurol"},{"key":"10.1016\/j.sleep.2025.108722_bib29","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"4","key":"10.1016\/j.sleep.2025.108722_bib30","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/jcm12041629","article-title":"Long-term use of insomnia medications: an appraisal of the current clinical and scientific evidence","volume":"12","author":"Zee","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.sleep.2025.108722_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/cts.13470","article-title":"Effect of discontinuation of lemborexant following long-term treatment of insomnia disorder: secondary analysis of a randomized clinical trial","volume":"16","author":"Takaesu","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.sleep.2025.108722_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.sleep.2021.01.048","article-title":"Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial","volume":"80","author":"Yardley","year":"2021","journal-title":"Sleep Med"},{"issue":"34","key":"10.1016\/j.sleep.2025.108722_bib33","first-page":"2960","article-title":"[Guidelines for the diagnosis and treatment of insomnia disorder","volume":"105","author":"Bin","year":"2025","journal-title":"Zhonghua Yixue Zazhi"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725023974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725023974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:18:09Z","timestamp":1773933489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725023974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S1389945725023974"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.108722","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorder","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.108722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108722"}}